Most Active Stocks

COCHINSHIP
BSE
INDIGO
SCI
GRSE
JUBLINGREA
BEL
HAL
RELIANCE
MAZDOCK
CDSL
ONGC
OIL
RPOWER
BDL
JUBLPHARMA
SBIN
HDFCBANK
INFY
GESHIP

Glenmark Pharmaceuticals Limited

Drug Manufacturers - Specialty & Generic | Healthcare

Company Overview

Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and sells generics, specialty products, and OTC pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, oncology, cardiology, diabetic, gynecology, gastroenterology, and anti-infective in the dosage forms of complex injectables and biologics, oral solids, liquids, topical products, drops, and respiratory/MDI/DPI/nasal sprays. Its product pipeline includes ISB 2001, a BCMA x CD38 x CD3 trispecific engagement by antibodies based on the T cell receptor trispecific antibody, which is in Phase 1 clinical trial for indication of relapsed/refractory multiple myeloma; ISB 1442, a CD38 x CD47 bispecific engagement by antibodies based on the T cell receptor biparatopic bispecific antibody that is in Phase 1 clinical trial for the treatment of relapsed/refractory multiple myeloma and acute myeloid leukemia; and GRC 65327, a Cbi-b inhibitor, which is in pre-clinical study for the indication of solid tumors. The company's pipeline also comprises ISB 880, an IL-1RAP antagonist monoclonal antibody, which is in Phase 1 clinical trial for the treatment of autoimmune diseases; and ISB 830, a telazorlimab OX40 antagonist antibody that is in Phase 2 clinical trial for the treatment of atopic dermatitis. In addition, the company offers Ryaltris nasal spray for the treatment of seasonal allergic rhinitis. The company was incorporated in 1977 and is based in Mumbai, India.

Key Information

Market Cap

457278488576

Current Price

1620.4

52 Week Range

1182.5 - 1830.95

Previous Close

1615.6

Open

1611.2

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Contact Details

Address

Glenmark House, B.D. Sawant Marg Chakala, Off Western Express Highway Andheri (East), Mumbai, 400099, India

Phone

+91-22401-89999

Fax

+91-22401-89986

Website

https://www.glenmarkpharma.com

Financials

Day Low

1589.0

Day High

1624.9

Dividend Yield

0.16

PE Ratio

43.233727

Earnings Per Share

37.48

Beta

0.196

EBITDA

24651030528

Book Value

304.497

EPS

61.03511

Company Officers

Name Title Age Year Born
Mr. Glenn Mario Saldanha Chairman, MD & CEO 54 1970
Ms. Cherylann Maria Pinto B.Pharm Executive Director of Corporate Services & Executive Director 57 1967
Mr. V. S. Mani Executive Director 59 1965
Mr. Harish Vinayak Kuber Company Secretary & Compliance Officer - -
Mr. Anurag Mantri President 53 1971
Mr. Alind Sharma President and Chief Human Resources Officer 53 1971
Mr. Ulhas R. Dhuppad President & Head of Global Pharmaceutical Development 57 1967
Mr. Indrajit Bose President & Chief Quality Officer - -
Mr. Brijlal Motwani President & Global Head of Formulation Operations - -
Mr. Alok Malik President & Business Head of India Formulations - -

Company Details

Stock History

Explore More Stocks